140 related articles for article (PubMed ID: 35116884)
21. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
Luo W; Wang L; Luo MH; Huang YZ; Yang H; Zhou Y; Jia HT; Wang XX
J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236
[TBL] [Abstract][Full Text] [Related]
22. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatic analysis and
Li W; Kong X; Huang T; Shen L; Wu P; Chen QF
Ann Transl Med; 2020 Nov; 8(21):1422. PubMed ID: 33313167
[TBL] [Abstract][Full Text] [Related]
24. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
25. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
[TBL] [Abstract][Full Text] [Related]
26. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
27. Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer.
Huang QR; Pan XB
Front Oncol; 2019; 9():712. PubMed ID: 31448228
[No Abstract] [Full Text] [Related]
28. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract][Full Text] [Related]
29. A 16-miRNA Prognostic Model to Predict Overall Survival in Neuroblastoma.
Wang J; Xiao D; Wang J
Front Genet; 2022; 13():827842. PubMed ID: 35846139
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
Xie M; Lv Y; Liu Z; Zhang J; Liang C; Liao X; Liang R; Lin Y; Li Y
Cancer Manag Res; 2018; 10():5759-5766. PubMed ID: 30532596
[TBL] [Abstract][Full Text] [Related]
31. A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma.
Lu Z; Wang C; Qu T; Feng Y
Biomed Res Int; 2022; 2022():9957604. PubMed ID: 36199758
[TBL] [Abstract][Full Text] [Related]
32. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
33. Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
Chen S; Gao C; Wu Y; Huang Z
Front Pharmacol; 2020; 11():544. PubMed ID: 32457603
[TBL] [Abstract][Full Text] [Related]
34. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
35. Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer.
Yin XH; Jin YH; Cao Y; Wong Y; Weng H; Sun C; Deng JH; Zeng XT
Front Oncol; 2019; 9():729. PubMed ID: 31448232
[No Abstract] [Full Text] [Related]
36. Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
Deng R; Cui X; Dong Y; Tang Y; Tao X; Wang S; Wang J; Chen L
Front Genet; 2021; 12():626764. PubMed ID: 33719338
[TBL] [Abstract][Full Text] [Related]
37. Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.
Liao X; Zhu G; Huang R; Yang C; Wang X; Huang K; Yu T; Han C; Su H; Peng T
Cancer Manag Res; 2018; 10():787-803. PubMed ID: 29713196
[TBL] [Abstract][Full Text] [Related]
38. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Wu K; Zhang C; Zhang C; Dai D
Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
[TBL] [Abstract][Full Text] [Related]
39. Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
Zhao JY; Wang F; Li Y; Zhang XB; Yang L; Wang W; Xu H; Liu DZ; Zhang LY
Med Sci Monit; 2015 Oct; 21():3222-30. PubMed ID: 26498375
[TBL] [Abstract][Full Text] [Related]
40. Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer.
Yin TF; Zhao DY; Zhou YC; Wang QQ; Yao SK
World J Clin Cases; 2021 Jun; 9(18):4520-4541. PubMed ID: 34222420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]